drugset / Trial / NCT02045056
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to assess the safety and efficacy of gemfibrozil in modulating microRNA-107 levels for the prevention of Alzheimer's disease in subjects with intact cognition and mild cognitive impairment
Timeline
- Start
- 2014-05
- Primary completion
- 2018-06-30
- Completion
- 2019-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemfibrozil | Small molecule | 600 mg | Oral |